Travere Therapeutics Shares Outstanding 2012-2021 | TVTX

Travere Therapeutics shares outstanding from 2012 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Travere Therapeutics Annual Shares Outstanding
(Millions of Shares)
2020 48
2019 42
2018 40
2017 39
2016 38
2015 38
2014 25
2013 14
2012 4
2011 2
Travere Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 61
2021-03-31 56
2020-12-31 48
2020-09-30 51
2020-06-30 45
2020-03-31 44
2019-12-31 42
2019-09-30 43
2019-06-30 42
2019-03-31 41
2018-12-31 40
2018-09-30 41
2018-06-30 40
2018-03-31 40
2017-12-31 39
2017-09-30 39
2017-06-30 39
2017-03-31 39
2016-12-31 38
2016-09-30 37
2016-06-30 37
2016-03-31 38
2015-12-31 38
2015-09-30 43
2015-06-30 35
2015-03-31 30
2014-12-31 25
2014-09-30 28
2014-06-30 27
2014-03-31 23
2013-12-31 14
2013-09-30 15
2013-06-30 12
2013-03-31 11
2012-12-31 4
2012-11-30 0
2012-09-30 4
2012-08-31 0
2012-06-30 3
2012-05-31 0
2012-03-31 3
2012-02-29
2011-12-31 2
2011-11-30 0
2011-09-30
2011-08-31 0
2011-06-30
2011-05-31 0
2011-03-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.500B $0.198B
Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29